Novotech Featured Reports

31. Rheumatoid Arthritis – Global Clinical Trial Landscape 3/11/2024

    While RA presents a substantial global health challenge, see how evolving therapies and research efforts offer hope for improved outcomes and better management of this debilitating condition.

32. Global Prevalence And Clinical Trials Landscape Of DMD 3/11/2024

    Stay informed with the latest advancements in the fight against Duchenne Muscular Dystrophy, a disease that impacts thousands of lives worldwide.

33. Exploring Global Clinical Research Perspectives On RA Insights 2/5/2024

    Explore how the research into Rheumatoid Arthritis, which affects 17.6 million people worldwide, aims to improve treatment effectiveness and future interventions.

34. Insights Into Candidiasis: Global Clinical Research Overview 2/5/2024

    Explore how drug-resistant strains are posing challenges when it comes to the treatment of candidiasis, but therapeutic advancements and ongoing research are offering hope for improved outcomes.

35. Candidiasis – Global Clinical Trial Landscape 1/31/2024

    Get an overview of the diverse therapeutic modalities in drug development as it relates to the clinical trial landscape and prospects in Candidiasis treatment.

36. Pros And Cons Of Basing Clinical Trials In Today's European Landscape 1/31/2024

    Explore the essential considerations for sponsors and CROs as they navigate the advantages and challenges of clinical trial locations, particularly in the United States and Europe.

37. Global Strides In HIV Research: Mapping The Clinical Trial Terrain 1/31/2024

    Uncover how ongoing research exploring innovative pathways is serving as a beacon of hope for HIV, promising not only an eventual cure but also an enhanced quality of life for those affected.

38. Metastatic Breast Cancer - Global Clinical Trial Landscape (2023) 11/27/2023

    Uncover why the collaboration between researchers, clinicians, regulatory bodies, and CROs remains crucial for innovative solutions and improved patient outcomes in the journey to address metastatic breast cancer challenges.

39. Dyslipidaemia – 2023 Global Clinical Trial Landscape 11/7/2023

    While APAC is at the forefront of dyslipidaemia research, gain insight into pharmaceutical companies' continued new treatment developments and innovative therapies.

40. Non-Small Cell Lung Cancer: Global Clinical Trial Landscape 11/7/2023

    Unearth how targeted medicines and immunotherapy have emerged as viable treatment options, offering hope for improved outcomes and quality of life for NSCLC patients.